Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | CPA1 | P15085 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.41 |
| ▸ | CPA3 | P15088 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29871382 | 0.82 | KMT2A (0.45) | CYP1A2KMT2AMEN1AKR1B1CPA1 | |
| SCHEMBL9705115 | 0.81 | ALPI (0.46) | CYP1A2KMT2AMEN1AKR1B1CPA1 | |
| SCHEMBL12869897 | 0.80 | MEN1 (0.54) | KMT2AMEN1NPC1RAB9ACA12 | |
| SCHEMBL847206 | 0.77 | LMNA (0.39) | CYP1A2KMT2AMEN1AKR1B1CPA1 | |
| SCHEMBL20135421 | 0.76 | KMT2A (0.46) | KMT2AMEN1NPC1RAB9ACA12 | |
| SCHEMBL20135418 | 0.76 | KMT2A (0.46) | KMT2AMEN1NPC1RAB9ACA12 | |
| SCHEMBL9667288 | 0.76 | CRHBP (0.42) | CYP1A2KMT2AMEN1CPA1LMNA | |
| SCHEMBL11169040 | 0.75 | CYP1A2 (0.48) | CYP1A2KMT2AMEN1NPC1RAB9A | |
| SCHEMBL27431307 | 0.74 | MIF (0.49) | CYP1A2KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL212272 | 0.74 | AKR1B1 (0.52) | KMT2AMEN1AKR1B1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0723194-B1 | Photographic bleaching compositions and processing method using ternary iron carboxylate complexes as bleaching agents | EASTMAN KODAK CO (US) | 2001-09-26 | — | — | EP | claimed |
| US-5602192-A | BLEND OF PHENOLIC BINDER AND ADJUVANT | KAO CORPORATION (JP) | 1997-02-11 | — | — | US | claimed |
| US-5582958-A | USEFUL IN REHALOGENATING FERRIC CHELATE BLEACHES | EASTMAN KODAK COMPANY (US) | 1996-12-10 | — | — | US | claimed |
| EP-0723194-A1 | Photographic bleaching compositions and processing method using ternary iron carboxylate complexes as bleaching agents | EASTMAN KODAK COMPANY (US) | 1996-07-24 | — | — | EP | claimed |
| US-5521056-A | BIODEGRADATION | EASTMAN KODAK COMPANY (US) | 1996-05-28 | — | — | US | claimed |
| JP-55127399-A | — | — | None | — | — | JP | disclosed |
| US-20250090437-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | MIYOSHI YUSHI KK (JP) | 2025-03-20 | — | — | US | disclosed |
| CN-113423470-B | Cosmetic compounding agent, cosmetic, and method for producing same | 三吉油脂株式会社 | 2024-07-09 | — | — | CN | disclosed |
| US-20220096349-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | MIYOSHI OIL & FAT CO., LTD. (JP) | 2022-03-31 | — | — | US | disclosed |
| EP-3925671-A1 | COSMETIC INGREDIENT, COSMETIC, AND PRODUCTION METHOD FOR COSMETIC | Miyoshi Oil & Fat Co., Ltd. (JP) | 2021-12-22 | — | — | EP | disclosed |
| CN-113423470-A | Cosmetic compounding agent, cosmetic and method for producing same | 三吉油脂株式会社 | 2021-09-21 | — | — | CN | disclosed |
| WO-2020166678-A1 | COSMETIC INGREDIENT, COSMETIC, AND PRODUCTION METHOD FOR COSMETIC | ミヨシ油脂株式会社 | 2020-08-20 | — | — | WO | disclosed |
| EP-0859276-A1 | Cyan dye recovery using ferric aminopolycarboxylic acid bleaching composition | EASTMAN KODAK COMPANY (US) | 1998-08-19 | — | — | EP | disclosed |
| US-5753423-A | ACID SOLUTIONS OF SUCCINIC ACID, MALEIC ACID OR MALIC ACID WITH AMINOPOLYCARBOXYLIC AID, MIXING FERRIC ION, ADDING BASE TO CHANGE PH | EASTMAN KODAK COMPANY (US) | 1998-05-19 | — | — | US | disclosed |
| US-5602192-A | BLEND OF PHENOLIC BINDER AND ADJUVANT | KAO CORPORATION (JP) | 1997-02-11 | — | — | US | disclosed |
| US-5582958-A | USEFUL IN REHALOGENATING FERRIC CHELATE BLEACHES | EASTMAN KODAK COMPANY (US) | 1996-12-10 | — | — | US | disclosed |
| EP-0723194-A1 | Photographic bleaching compositions and processing method using ternary iron carboxylate complexes as bleaching agents | EASTMAN KODAK COMPANY (US) | 1996-07-24 | — | — | EP | disclosed |
| US-5521056-A | BIODEGRADATION | EASTMAN KODAK COMPANY (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0465919-A1 | Process for producing sand mold | Kao Corporation (JP) | 1992-01-15 | — | — | EP | disclosed |
| JP-S55127399-A | PRODUCTION OF OIL-SOLUBLE ORGANIC COMPOUND THAT CAN CAUSE CHELATION | SUMITOMO BAKELITE CO LTD | 1980-10-02 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096349-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | H1-0, H1-4, H1-2 | CYP1A2 3713/4885KMT2A 1367/4885MEN1 272/4885 |
| US-20250090437-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | CUTA, HAT1, NACA | CYP1A2 3994/4885KMT2A 961/4885MEN1 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.